CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

NCT06262438 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia in Children

Interventions

DRUG: Quizartinib
DRUG: Etoposide
DRUG: Dexrazoxane
DRUG: Mitoxantrone
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Daunorubicin
DRUG: Fludarabine
OTHER: allo-SCT

Sponsor

Princess Maxima Center for Pediatric Oncology

Collaborators

[object Object]